JPMorgan Initiates Coverage On Bharat Electronics With “Outperform” Rating
Bharat Electronics Ltd. is poised to benefit from the Narendra Modi government's growing outlay on defence, focus on import substitution and modernisation, according to JPMorgan.
The brokerage firm initiated coverage on the stock with an "Outperform" rating, and a target price of Rs 185, which indicates an upside of 19 percent from Monday's closing price. The consensus target price of 25 analysts tracking the stock stands at Rs 192, according to data available on Bloomberg. 17 of those analysts have a "Buy" rating on the stock, while three have a "Sell" rating.
"BEL's position benefits from its strong research and development focus, improving indigenisation levels, growing manufacturing footprint and solid execution track record. A sizable non-defense and export opportunity could augment future growth," JPMorgan analysts wrote in a report dated March 5.
Over FY18-20E, we expect BEL to deliver compounded annual growth rate of 13 percent in revenues, 15 percent in EBITDA (earnings before interest, taxes, depreciation, and amortisation) and 17 percent in profits.JPMorgan Report

BEL's organic growth prospects, higher margin profile, and scope for further return on equity expansion merits a 15 percent valuation premium to the estimated FY20 average price-to-earnings of global defence majors, according to the brokerage.
The defence electronics equipment maker trades at 26.5 times trailing 12-month earnings per share and 22 times its estimate for the coming year.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.